란셋 시장 규모 : 유형, 크기 및 최종 용도별 - 세계 예측(2023-2032년)

Global Lancet Market size will exhibit 4.7% CAGR from 2023 to 2032, driven by the growing prevalence of diabetes worldwide. According to WHO, diabetes affects approximately 422 million individuals globally, with the majority residing in low- and middle-income nations. Each year, diabetes directly contributes to 1.5 million fatalities.

As more individuals require regular blood glucose monitoring, lancets, crucial for obtaining blood samples, will witness increased demand. The emphasis on self-care and early disease management in diabetes management further propels the lancet market, as patients seek convenient and efficient tools for monitoring their condition, creating opportunities for market expansion.

The overall lancet market is categorized based on type, size, end-use, and region.

The safety lancets industry could demonstrate 5.2% CAGR between 2023 and 2032. The demand for safety lancets is gaining momentum due to growing concerns for healthcare worker safety and infection control. These innovative devices offer a safer and more hygienic way to obtain blood samples, reducing the risk of needlestick injuries and cross-contamination. Consequently, healthcare facilities and professionals are increasingly adopting safety lancets to enhance workplace safety and patient care.

Clinics could emerge as a prominent end-user for lancets, with the segment size expanding at 4.6% CAGR through 2032, driven by the need for efficient and precise blood sampling for diagnostic purposes. Lancets provide a quick and relatively painless way to obtain blood samples for various medical tests. With clinics serving a diverse patient population, the reliability and ease of use of lancets make them essential tools for healthcare professionals, contributing to their high demand in clinical settings.

Europe lancet industry is witnessing substantial growth due to the region's aging population, increased prevalence of chronic diseases like diabetes, and a strong emphasis on healthcare quality and patient safety. According to Eurostat, in 2022, the old-age dependency ratio in the EU stood at 33%, showing a 0.5 percentage point rise from the previous year and indicating a consistent upward trend. Over the decade since 2012, this indicator has increased by 5.9 percentage points, starting from 27.1% in that year. These factors drive the demand for lancets, essential for blood glucose monitoring and diagnostics, contributing to the industry's robust expansion in Europe.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definitions
• 1.2 Base estimates & working
  • 1.2.1 Data collection
• 1.3 Forecast calculations
• 1.4 COVID-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Lancet industry 360 degree synopsis, 2018 - 2032 (USD Million)
• 2.2 Business trends
• 2.3 Regional trends (USD Million & Units)
• 2.4 Type trends (USD Million & Units)
• 2.5 Size trends
• 2.6 End-use trends

Chapter 3 Lancet Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing prevalence of diabetes across the world
    • 3.2.1.2 Rising technological advancements
    • 3.2.1.3 Increasing investments by public and private organizations for diabetes care
    • 3.2.1.4 Upsurge in geriatric population base
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Increasing number of infections and injuries from lancets
    • 3.2.2.2 Rigorous regulatory framework regarding diabetes care
• 3.3 Growth potential analysis
  • 3.3.1 By type
  • 3.3.2 By size
  • 3.3.3 By end-use
• 3.4 COVID-19 impact analysis
• 3.5 Technology landscape
• 3.6 Regulatory landscape
  • 3.6.1 U.S.
  • 3.6.2 Europe
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive dashboard, 2022
• 4.4 Company market share analysis, 2022
• 4.5 Vendor matrix analysis, 2022
• 4.6 Competitive analysis of major market players
• 4.7 Competitive positioning matrix
• 4.8 Strategic outlook matrix

Chapter 5 Lancet Market Size and Forecast, By Type (USD Million & Units)

• 5.1 Key trends, by type
• 5.2 Safety lancets
• 5.3 Standard lancets
• 5.4 Manually activated lancets
  • 5.4.1 Push button lancets
  • 5.4.2 Side button lancets
• 5.5 Automatically activated lancets

Chapter 6 Lancet Market Size and Forecast, By Size (USD Million)

• 6.1 Key trends, by size
• 6.2 22G and below
• 6.3 23G-33G
• 6.4 Above 33G

Chapter 7 Lancet Market Size and Forecast, By End-use (USD Million)

• 7.1 Key trends, by end-use
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Homecare settings
• 7.5 Ambulatory surgical centers
• 7.6 Others

Chapter 8 Lancet Market Size and Forecast, By Region (USD Million & Units)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Switzerland
  • 8.3.7 The Netherlands
  • 8.3.8 Denmark
  • 8.3.9 Poland
  • 8.3.10 Sweden
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 New Zealand
  • 8.4.7 Vietnam
  • 8.4.8 Indonesia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Colombia
  • 8.5.5 Chile
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Turkey

Chapter 9 Company Profiles

• 9.1 AgaMatrix
• 9.2 Abbott Laboratories
• 9.3 All Medicus Co., Ltd.
• 9.4 Ascensia Diabetes Care Holdings AG
• 9.5 Arkray, Inc
• 9.6 B. Braun Melsungen AG
• 9.7 Bionime Corporation
• 9.8 DarioHealth Corp.
• 9.9 Dexcom, Inc.
• 9.10 Essenlife Bioscience, Inc.
• 9.11 F. Hoffmann-La Roche Ltd.
• 9.12 LifeScan Inc.
• 9.13 Medtronic
• 9.14 Nova Biomedical, Inc.
• 9.15 Sinocare Inc.